ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Interventional Cardiology

Top Interventional Cardiology Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DON LEE M.D.

Interventional Cardiology

42,707

$3.03M

2037
1850 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 28%

$71
Average prescription price

Avg: $69

KWAN CHEN MD

Interventional Cardiology

17,239

$1.82M

859
773 are 65+

1%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 28%

$105
Average prescription price

Avg: $69

MARK MILLER M.D.

Interventional Cardiology

12,145

$820K

704
644 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 28%

$67
Average prescription price

Avg: $69

ATHAR ANSARI M.D.

Interventional Cardiology

11,046

$767K

1089
910 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 28%

$69
Average prescription price

Avg: $69

LAWRENCE O'CONNOR M.D.

Interventional Cardiology

10,856

$932K

709
643 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 28%

$86
Average prescription price

Avg: $69

NICHOLAS DOAN VAN MD, F.A.C.C. INC.

Interventional Cardiology

10,464

$522K

544
512 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 28%

$50
Average prescription price

Avg: $69

JOSE CACERES MD

Interventional Cardiology

10,023

$738K

445
338 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

18%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 28%

$74
Average prescription price

Avg: $69

YUNG-HSI WEN M.D.

Interventional Cardiology

8,754

$764K

553
510 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 28%

$87
Average prescription price

Avg: $69

THANH NGUYEN D.O

Interventional Cardiology

7,579

$494K

318
294 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 28%

$65
Average prescription price

Avg: $69

EUGENE MOFFETT M.D.

Interventional Cardiology

7,481

$543K

684
618 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 28%

$73
Average prescription price

Avg: $69

CHRISTAKIS CHRISTODOULOU M.D.

Interventional Cardiology

7,455

$775K

493
428 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 28%

$104
Average prescription price

Avg: $69

JOSEPH ARAGON M.D.

Interventional Cardiology

7,236

$404K

662
629 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $69

ROBERT CORONADO M.D.

Interventional Cardiology

7,171

$361K

633
523 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 28%

$50
Average prescription price

Avg: $69

CHARLES SOHN MD

Interventional Cardiology

7,169

$434K

793
665 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 28%

$61
Average prescription price

Avg: $69

SAM BORNO MD

Interventional Cardiology

7,089

$478K

941
868 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 28%

$67
Average prescription price

Avg: $69

CHENGALROYAN RAGHUANTHAN MD

Interventional Cardiology

7,016

$612K

387
311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 28%

$87
Average prescription price

Avg: $69

ANDREW BENN MD

Interventional Cardiology

6,905

$601K

533
507 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 28%

$87
Average prescription price

Avg: $69

SAMI NAZZAL M.D.

Interventional Cardiology

6,802

$599K

480
413 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 28%

$88
Average prescription price

Avg: $69

ROMAN SZKOPIEC M.D.

Interventional Cardiology

6,773

$184K

470
429 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 28%

$27
Average prescription price

Avg: $69

JAY SCHAPIRA MD

Interventional Cardiology

6,733

$419K

449
416 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 28%

$62
Average prescription price

Avg: $69

ALTAF ALI M.D.

Interventional Cardiology

6,563

$365K

727
607 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 28%

$56
Average prescription price

Avg: $69

HOSSEIN SADEGHI M.D.

Interventional Cardiology

6,511

$306K

390
352 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 28%

$47
Average prescription price

Avg: $69

MEHRDAD ARIANI

Interventional Cardiology

6,308

$658K

513
477 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 28%

$104
Average prescription price

Avg: $69

AGUSTIN ARGENAL M.D.

Interventional Cardiology

6,208

$617K

690
634 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 28%

$99
Average prescription price

Avg: $69

HOSSEIN SHENASA MD

Interventional Cardiology

6,080

$540K

480
460 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 28%

$89
Average prescription price

Avg: $69

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank